Ductal Carcinoma in Situ: Non-invasive Breast Cancer

Dr. Ram Eitan

Oncologist

Treatment of ductal carcinoma in situ must be extremely careful: despite the seemingly "innocent" nature of this tumour, it should not be forgotten that it is prone to recurrence, and already in an invasive form. At Top Ihilov Clinic, experienced specialists treat ductal breast cancer, using all their knowledge and skills to give the tumour no chance.

Calculate treatment cost

Table of contents

Treatment methods

Diagnosis

Prices

Ductal Carcinoma in Situ (ductal cancer, DCIS) is the most common form of non-invasive breast cancer. Many doctors claim that ductal carcinoma in situ is safe for women's health, as the tumour does not spread to healthy breast tissue. Israeli specialists disagree with such a statement. Firstly, carcinoma in situ can progress to an invasive form; secondly, inadequately treated ductal cancer increases the risk of disease recurrence, but already in its aggressive form. Specialists from the Israeli Top Ihilov Clinic have effectively treated DCIS for many years. Comprehensive treatment and an individual approach to each patient are the keys to a low percentage of breast cancer recurrences among patients at Top Ihilov Medical Center.

Treatment of ductal breast cancer in Israel

Ductal Carcinoma in Situ is often referred to as precancer, so receiving treatment from an incompetent doctor who is unaware of the high risk of disease recurrence and believes that the tumour can simply be removed and forgotten about is deadly dangerous. In Israel, at Top Ihilov Medical Center, doctors exclusively practice comprehensive therapy aimed at the complete removal of all cancer cells and reducing the risk of tumour recurrence in the future. Comprehensive treatment consists of the following procedures:

• Surgical excision of the neoplasm — lumpectomy. The clinic's surgeons adhere to international standards for performing this operation: the edges of the removed tumour from the breast must be "clean", meaning they should not contain cancer cells. Thus, by capturing some healthy tissue, doctors prevent cancer cells from "hiding" in the breast and starting to develop.
• Radiation therapy. According to Israeli doctors, postoperative radiation therapy should be performed as a matter of course, as radiation allows for the destruction of atypical cells that may have remained after surgery.
• Hormonal therapy. This is conducted if DCIS is a hormone-dependent tumour.

This approach to treating patients with ductal breast cancer is currently considered the most optimal and is practiced in medically advanced countries such as Israel, Germany, and the USA.

Diagnosis of ductal carcinoma in situ

Diagnosis of ductal breast cancer in Israel is carried out using highly informative and at the same time painless and non-traumatic methods for the patient. At Top Ihilov Clinic, the following diagnostic program is used to confirm the diagnosis of "ductal carcinoma in situ":

• Mammography, during which in the case of ductal breast cancer, the doctor identifies microcalcifications on the mammogram.
• Fine-needle aspiration biopsy. A small amount of tissue is "suctioned" from the breast tissue using a syringe with a thin needle. After this procedure, the patient is left with no visible scar.
• Core needle biopsy. A larger diameter needle is inserted through a small incision in the skin of the breast to obtain more tissue. A small scar from the needle insertion disappears within a couple of weeks.

Cost of treatment for ductal carcinoma in situ at Top Ihilov